Shopping Cart
Remove All
Your shopping cart is currently empty
MEDI0639 (21H3RK) is a human monoclonal antibody (mAb) targeting DLL4. It inhibits the interaction between Notch1 and Dll4 and reverses Notch1-mediated inhibition of in vitro human umbilical vein endothelial cell growth. Additionally, MEDI0639 enhances human angiogenesis and reduces the number of smooth muscle actin-positive mural cell-covered vessels. This compound can be used in research on small cell lung cancer and solid tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | MEDI0639 (21H3RK) is a human monoclonal antibody (mAb) targeting DLL4. It inhibits the interaction between Notch1 and Dll4 and reverses Notch1-mediated inhibition of in vitro human umbilical vein endothelial cell growth. Additionally, MEDI0639 enhances human angiogenesis and reduces the number of smooth muscle actin-positive mural cell-covered vessels. This compound can be used in research on small cell lung cancer and solid tumors. |
| Synonyms | 21H3RK |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.